Browsing by Author "Van Buren, Charles T."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Immunosupportive drug sparing diet(2004-03-16) Van Buren, Charles T.; Rudolph, Frederick B.; Board of Regents of the University of Texas System; Rice University; United States Patent and Trademark OfficeThe present invention is directed to immunosupportive, drug sparing diets and methods of using these diets. The compositions and methods disclosed herein increase the bioavailability of pharmaceutical compositions metabolized by the gut P450 isozymes.Item Method and compositions for promotion of wound treatment(2002-01-29) Kulkarni, Anil D.; Van Buren, Charles T.; Rudolph, Frederick B.; Board of Regents of the University of Texas System; Rice University; United States Patent and Trademark OfficeThe present invention comprises compositions and preparations for the promotion of wound healing in an animal. Methods for preparing the compositions as well as methods for using the compositions to achieve the promotion of wound healing, are also provided. The composition may comprise a dietary regimen or a therapeutic agent. These compositions include a wound healing promoting concentration of nucleotides. By way of example, such nucleotides may comprise RNA, adenine, uracil or a mixture thereof. The compositions can be prepared as suitable for oral, parenteral, intravenous or topical administration. Methods for using the preparation as a treatment to enhance the healing of an already existing wound or for use as a pretreatment regimen for animals in anticipation of surgery, are also disclosed.Item Ribonucleotide preparations and uses thereof(1998-01-27) Kulkarni, Anil D.; Van Buren, Charles T.; Rudolph, Frederick B.; Board of Regents of the University of Texas System; Rice University; United States Patent and Trademark OfficeThe present invention comprises compositions and preparations for the promotion of wound healing in an animal. Methods for preparing the compositions as well as methods for using the compositions to achieve the promotion of wound healing are also provided. Methods for enhancing collagen production at a wound site are also disclosed. The composition may comprise a dietary regimen or a therapeutic agent. These compositions include a wound healing promoting concentration of ribonucleotides in a pharmaceutically acceptable carrier solution. By way of example, such ribonucleotides may comprise RNA, adenine, uracil or a mixture thereof. The compositions can be prepared as suitable for oral, parenteral, intravenous or topical administration. Methods for using the preparation as a treatment to enhance the healing of an already existing wound or for use as a pretreatment regimen for animals in anticipation of surgery, are also disclosed.